Literature DB >> 15847059

Intracellular cytokine patterns of peripheral blood T cells as a useful indicator of activeness of Crohn's disease.

Yoshio Ogura1, Yuji Imamura, Yoshiaki Murakami, Yoshio Takesue, Takashi Yokoyama, Taijiro Sueda, Eiso Hiyama.   

Abstract

Recently, the alteration of peripheral T cells has become a focus of attention in research on Crohn's disease (CD). To examine the characteristics of peripheral T cells in CD patients, we analyzed the expression of a memory T cell marker (CD45RO(Bright)CD3+) and the cytokine production by peripheral helper and cytotoxic T cells in patients with CD. With the use of monensin to prevent the secretion of cytokines under stimulation, we measured the count of intracellular cytokine-positive cells for production of interferon (IFN)-gamma, tumor necrosis factor (TNF)-alpha, interleukin (IL)-2, IL-4, IL-6, IL-10, and granulocyte-macrophage colony stimulating factor (GM-CSF) in the peripheral T cell population using flow-cytometry. The counts of lymphocytes, T cells, and helper T cells in patients with CD were significantly lower than in normal volunteers. Although no difference in the counts of lymphocytes, total T cells, helper and cytotoxic T cells was observed, the counts of intracellular cytokine producing helper T cells in IFN-gamma, TNF-alpha or GM-CSF were significantly higher in active cases than in quiescent cases. These results suggest that stable CD patients are immunosuppressive, and activation of some kinds of T-cells, especially Th1-associated cytokine producing T-cells, correlate with disease progression. Th1-associated cytokine analysis of peripheral T cells may be one of the useful markers to evaluate the activeness of Crohn's disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15847059

Source DB:  PubMed          Journal:  Hiroshima J Med Sci        ISSN: 0018-2052


  3 in total

1.  Critical comment: analyzing the effect of novel therapies on cytokine expression in inflammatory bowel disease: do cytokine levels reflect clinical response?

Authors:  B M Wittig; M Zeitz
Journal:  Int J Colorectal Dis       Date:  2006-01-17       Impact factor: 2.571

2.  Impaired peripheral Th1 CD4+ T cell response to Escherichia coli proteins in patients with Crohn's disease and ankylosing spondylitis.

Authors:  Asgar Ergin; Uta Syrbe; Rebecca Scheer; Andreas Thiel; Thomas Adam; Konrad Büssow; Rainer Duchmann; Martin Zeitz; Joachim Sieper
Journal:  J Clin Immunol       Date:  2011-09-08       Impact factor: 8.317

3.  Successful treatment with infliximab for inflammatory colitis in a patient with X-linked anhidrotic ectodermal dysplasia with immunodeficiency.

Authors:  Tomoyuki Mizukami; Megumi Obara; Ryuta Nishikomori; Tomoki Kawai; Yoshihiro Tahara; Naoki Sameshima; Kousuke Marutsuka; Hiroshi Nakase; Nobuhiro Kimura; Toshio Heike; Hiroyuki Nunoi
Journal:  J Clin Immunol       Date:  2011-10-13       Impact factor: 8.317

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.